Stefan E Pambuccian
Overview
Explore the profile of Stefan E Pambuccian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
188
Citations
1662
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gupta S, Noona S, Pambuccian S, Robinson B, Martin L, Williams E, et al.
Hum Pathol
. 2022 Dec;
134:56-65.
PMID: 36549598
Undifferentiated SMARCA4-deficient carcinoma of the esophagus and gastroesophageal junction is a rare, highly aggressive, and diagnostically challenging malignancy. Here we present a case series of high-grade undifferentiated malignant neoplasms of...
2.
Tang P, Moravek M, Oprea-Ilies G, Mon K, Pambuccian S
Pathol Res Pract
. 2022 Aug;
237:154070.
PMID: 36030639
Lymph node metastasis is the most important prognostic factor for breast cancer patients. In addition to the number of nodes involved and the largest metastatic focus, extranodal extension (ENE) is...
3.
Trabzonlu L, Chatt G, McIntire P, Eshraghi R, Lapadat R, Atieh M, et al.
J Am Soc Cytopathol
. 2022 Apr;
11(4):218-225.
PMID: 35469774
Introduction: Telecytology offers a suitable solution to the cost and time efficiency questions on rapid onsite evaluation (ROSE). An increasing number of institutions are adopting new telecytology systems to meet...
4.
McIntire P, Aragao A, Burns B, Pambuccian S, Wojcik E, Barkan G
Cancer Cytopathol
. 2022 Feb;
130(5):363-369.
PMID: 35104393
Background: The Paris System for Reporting Urinary Cytology (TPS) uses hyperchromasia as major diagnostic criterion for high-grade urothelial carcinoma (HGUC). The purpose of the study was to evaluate cases that...
5.
Mon K, Kilic I, Barkan G, Pambuccian S
Diagn Cytopathol
. 2021 Apr;
49(6):773-778.
PMID: 33908708
No abstract available.
6.
Chen H, Lapadat R, Lastra R, Biernacka A, Reeves W, Mueller J, et al.
Acta Cytol
. 2021 Feb;
65(2):140-149.
PMID: 33535202
Background: Fine needle aspiration (FNA) of renal masses can distinguish between benign and malignant neoplasms in 73-94% of cases. Previous studies suggested the correct subclassification of renal cell carcinomas (RCCs)...
7.
Nomani L, Abro S, Chatt G, Abdulameer S, Pambuccian S, Mehrotra S, et al.
J Am Soc Cytopathol
. 2021 Jan;
10(2):141-147.
PMID: 33422455
Introduction: According to the Clinical Laboratory Improvement Amendments 1988 regulations, 5-year retrospective review (5YRR) of normal Papanicolaou tests in patients with a newly diagnosed high grade squamous intraepithelial lesion or...
8.
Abro S, Nomani L, Wojcik E, Pambuccian S, Chatt G, Barkan G
J Am Soc Cytopathol
. 2020 Dec;
10(1):64-70.
PMID: 33279453
Introduction: The Paris System (TPS) for Reporting Urinary Cytology (UCyto) was published in 2016, but to date, no study addressing the unsatisfactory (UNSAT) category has been published. We aimed to...
9.
Trabzonlu L, Atieh M, Pambuccian S
Diagn Cytopathol
. 2020 Nov;
49(5):661-663.
PMID: 33237625
No abstract available.
10.
McIntire P, Kilic I, Pambuccian S, Wojcik E, Barkan G
J Am Soc Cytopathol
. 2020 Nov;
10(1):14-19.
PMID: 33221245
Introduction: The Paris System for Reporting Urinary Cytology (TPS) was developed for standardization purposes and it placed an emphasis on screening for high-grade urothelial carcinoma (HGUC). Since then, it has...